MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Charles River Laboratories International Total Shareholders Equity 2011-2026 | CRL
Annual Total Shareholders Equity Charles River Laboratories International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.16 B | 3.46 B | 3.6 B | 2.98 B | 2.54 B | 2.12 B | 1.63 B | 1.32 B | 1.05 B | 837 M | 733 M | 672 M | 641 M | 601 M | 526 M | 687 M | 1.38 B | 1.24 B | 1.91 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.6 B | 526 M | 1.64 B |
Quarterly Total Shareholders Equity Charles River Laboratories International
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.94 B | 3.41 B | 3.35 B | 3.19 B | 3.46 B | 3.79 B | 3.73 B | 3.65 B | 3.6 B | 3.31 B | 3.26 B | 3.11 B | 2.98 B | 2.63 B | 2.65 B | 2.61 B | 2.53 B | 2.43 B | 2.32 B | 2.18 B | 2.11 B | 2.11 B | 2.11 B | 2.11 B | 1.63 B | 1.63 B | 1.63 B | 1.63 B | 1.32 B | 1.32 B | 1.32 B | 1.32 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 837 M | 837 M | 837 M | 837 M | 733 M | 733 M | 733 M | 733 M | 672 M | 672 M | 672 M | 672 M | 641 M | 641 M | 641 M | 641 M | 601 M | 601 M | 601 M | 601 M | 526 M | 526 M | 526 M | 526 M | 1.04 B | 1.4 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.79 B | 526 M | 1.68 B |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ICON Public Limited Company
ICLR
|
9.19 B | $ 118.45 | 4.04 % | $ 9.77 B |  Irlanda |
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
5.39 B | $ 115.84 | 0.68 % | $ 35.2 B | USA |
 |
Celcuity
CELC
|
101 M | $ 133.97 | -0.22 % | $ 6.26 B | USA |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 7.3 | -19.87 % | $ 9.71 M | USA |
 |
Castle Biosciences
CSTL
|
471 M | $ 21.26 | 7.97 % | $ 616 M | USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-56 M | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
1.11 B | $ 17.9 | 1.3 % | $ 551 M | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-99.3 M | $ 127.51 | 6.39 % | $ 16 B | USA |
 |
CareDx, Inc
CDNA
|
303 M | $ 22.16 | 2.88 % | $ 1.18 B | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
3.44 M | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.8 | - | $ 7.96 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
2.37 B | $ 150.17 | 3.41 % | $ 23.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M |  China |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 99.09 | -0.97 % | $ 6.69 B | USA |
 |
Genetic Technologies Limited
GENE
|
1.83 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
-23.6 M | $ 1 093.84 | -0.68 % | $ 22.5 B |  Schweiz |
 |
NeoGenomics
NEO
|
837 M | $ 9.57 | 3.24 % | $ 1.23 B | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 428.0 | -0.26 % | $ 12.3 B | USA |
 |
National Research Corporation
NRC
|
14 M | $ 19.13 | 0.47 % | $ 428 M | USA |
 |
Natera
NTRA
|
706 M | $ 203.11 | 1.1 % | $ 20 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
368 M | $ 3.94 | 2.34 % | $ 365 M | USA |
 |
Personalis
PSNL
|
261 M | $ 9.49 | 6.15 % | $ 847 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
11 B | $ 26.6 | -1.26 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
61 M | $ 6.32 | -1.71 % | $ 264 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
450 M | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
473 M | $ 64.17 | -1.08 % | $ 3.84 B | USA |
 |
Biomerica
BMRA
|
4.1 M | $ 2.46 | -0.61 % | $ 5.65 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 258.25 | -0.08 % | $ 21.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
53.4 B | $ 456.21 | 1.79 % | $ 172 B | USA |
 |
Waters Corporation
WAT
|
2.56 B | $ 342.18 | 1.05 % | $ 20.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
-35.2 M | $ 0.68 | 5.04 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.2 | 0.66 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 193.99 | 0.58 % | $ 21.5 B | USA |